Prochlorperazine Edisylate Injection
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Prochlorperazine Edisylate Injection is a sterile solution of Prochlorperazine Edisylate in Water for Injection. It contains an amount of prochlorperazine edisylate equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of prochlorperazine (C₂₀H₂₄ClN₃S).
[Note—Throughout the following procedures, protect the sample, the Reference Standard, and solutions containing them, by conducting the procedures without delay, under subdued light, or using low-actinic glassware.]
2 IDENTIFICATION
A. Identification—Organic Nitrogenous Bases 〈181〉: Meets the requirements when USP Prochlorperazine Maleate RS is used as the standard for comparison
3 ASSAY
Procedure
Buffer: 2.68 g/L of dibasic sodium phosphate heptahydrate in water, adjusted with phosphoric acid to a pH of 3.0
Mobile phase: Acetonitrile and Buffer (7:3)
Standard solution: Equivalent to 0.1 mg/mL of prochlorperazine, from USP Prochlorperazine Maleate RS in Mobile phase
Sample solution: Transfer a portion of Injection, equivalent to 10 mg of prochlorperazine, to a 100-mL volumetric flask, and dilute with Mobile phase to volume.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; packing L1
Column temperature: 40°
Flow rate: 1.5 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 3000 theoretical plates
Tailing factor: NMT 2.5
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of prochlorperazine (C₂₀H₂₄ClN₃S) in the portion of Injection taken:
Result = (r₁ / r₂) × (C₁ / C₂) × 100
r₁ = peak response from the Sample solution
r₂ = peak response from the Standard solution
C₁ = concentration of prochlorperazine in the Standard solution (mg/mL)
C₂ = nominal concentration of prochlorperazine in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 SPECIFIC TESTS
Bacterial Endotoxins Test 〈85〉: NMT 17.9 USP Endotoxin Units/mg of prochlorperazine
pH 〈791〉: 4.2–6.2
Other Requirements: It meets the requirements in Injections and Implanted Drug Products 〈1〉
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in single-dose or in multiple-dose containers, preferably of Type I glass, protected from light.
USP Reference Standards 〈11〉

